SHL Expands U.S. Operations With SHL Pharma Systems

SHL is continuing to expand operations in the United States with the establishment of SHL Pharma Systems, a state-of-the-art final assembly and packaging operation. Located in South Florida, this new facility will offer final assembly, labeling, and packaging services to SHL's pharmaceutical and biotechnology customers.

“We are excited about this latest expansion project as it is very customer driven,” says Lucio Giambattista, executive VP, SHL Group, and managing director, SHL Medical USA. “We have built up close relationships with some of the world's largest pharma and biotech companies over the years and this facility will allow us to offer even more services to these partners. Now, with packaging, labeling and distribution services available in-house, SHL will truly be a one-stop-shop for drug delivery devices, from product design to delivery.

SHL (shl-group.com) has been significantly expanding facilities and recruiting new employees as the result of several recently signed long-term supply agreements. SHL has publicly announced capital expenditures of more than $100 million. The company is forecasting to hire an additional 1,000 new employees during the next few years in addition to the 1,500 members of existing staff. The new Florida facility is scheduled to be operational in the first quarter of 2011.

SHL is a privately owned designer, developer, and manufacturer of advanced drug-delivery devices. The company employs more than 1,500 staff globally with about 1,000 employees in Taiwan. Primary design centers are located in the United States and Sweden and manufacturing centers located in Asia. SHL supplies auto injectors, pen injectors, and inhaler systems to global pharmaceutical and biotechnology companies.

Significant investment in R&D has enhanced the company’s broad pipeline of next-generation, drug-delivery systems. These devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision, and the ability to accommodate high viscosities.

The organization comprises three distinct group companies. SHL Medical Designs develops and manufactures advanced drug-delivery devices for pharmaceutical and biotechnology companies. SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use. SHL Technologies provides contract manufacturing and engineering services for the production of complex medical technology and industrial products.